LIGAND PHARMACEUTICALS INCORPORATED
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2017 | $29.3M | $10.2M | $45.3M |
| Jun 2017 | $28.0M | $13.0M | $73.2M |
| Sep 2017 | $33.4M | $16.5M | $67.4M |
| Dec 2017 | $50.5M | — | $-42.5M |
| Mar 2018 | $56.2M | $37.0M | $45.3M |
| Jun 2018 | $90.0M | $70.2M | $73.2M |
| Sep 2018 | $45.7M | $23.4M | $67.4M |
| Dec 2018 | $59.6M | — | $-42.5M |
| Mar 2019 | $43.5M | $826.5M | $666.3M |
| Jun 2019 | $25.0M | $-4.1M | $-14.4M |
| Sep 2019 | $24.8M | $-5.2M | $-15.3M |
| Dec 2019 | $27.0M | — | $-7.4M |
| Mar 2020 | $33.2M | $3.8M | $-24.1M |
| Jun 2020 | $41.4M | $7.1M | $22.1M |
| Sep 2020 | $41.8M | $3.7M | $-6.7M |
| Dec 2020 | $70.0M | — | $5.8M |
| Mar 2021 | $46.6M | $4.7M | $18.1M |
| Jun 2021 | $78.9M | $45.7M | $30.7M |
| Sep 2021 | $59.7M | $15.7M | $13.7M |
| Dec 2021 | $56.4M | — | $-5.4M |
| Mar 2022 | $36.5M | $2.1M | $-15.4M |
| Jun 2022 | $50.1M | $8.7M | $-895.0K |
| Sep 2022 | $59.2M | $12.3M | $404.0K |
| Dec 2022 | $50.4M | — | $-17.5M |
| Mar 2023 | $44.0M | $14.2M | $41.9M |
| Jun 2023 | $26.4M | $-2.0M | $2.3M |
| Sep 2023 | $32.9M | $3.1M | $-10.3M |
| Mar 2024 | $31.0M | $3.0M | $86.1M |
| Jun 2024 | $41.5M | $-19.1M | $-51.9M |
| Sep 2024 | $51.8M | $3.1M | $-7.2M |
| Mar 2025 | $45.3M | $-36.2M | $-42.5M |
| Jun 2025 | $47.6M | $8.4M | $4.8M |
| Sep 2025 | $115.5M | $54.9M | $117.3M |
| Mar 2026 | $51.7M | $17.4M | $-13.3M |
| Jun 2026 | $63.7M | $8.6M | $48.5M |